Manzo Pharmaceuticals, Inc.
MNZO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$500K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $500,000.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -0.54 |
| Outstanding Shares | 5,000,000,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.98 |
|---|---|
| PEG | 0.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Manzo Pharmaceuticals, Inc.
12 employees
CEO: Kenneth Manzo
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a paten...